Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer
Abstract:
Brain metastases are common in patients with non-small-cell lung cancer (NSCLC). Because of associated poor prognosis and limited specific treatment options, there is a real need for the development of medical therapies and strategies for affected patients. Novel compounds for epidermal growth factor receptor-dependent and anaplastic lymphoma kinase-dependent lung cancer have demonstrated blood-brain barrier permeability and have led to important improvements in central nervous system outcomes. Studies of targeted therapies for oncogene-driven tumors and of immunotherapies in patients with brain metastases have shown promise and, allied with novel radiation techniques, are driving a rapid evolution in treatment and prognosis for NSCLC brain metastases.
Insights
Brain metastases are a significant challenge in non-small-cell lung cancer (NSCLC). Targeted therapies and immunotherapies show promise for improving outcomes in patients with brain metastases.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Background:
- Brain metastases frequently occur in non-small-cell lung cancer (NSCLC) patients.
- Limited treatment options and poor prognosis highlight the need for novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in treating NSCLC brain metastases.
- To discuss the role of targeted therapies and immunotherapies in improving central nervous system outcomes.
Main Methods:
- Review of current literature on targeted therapies and immunotherapies for NSCLC brain metastases.
- Analysis of novel compounds demonstrating blood-brain barrier permeability.
- Integration of findings with advancements in radiation techniques.
Main Results:
- Targeted therapies for EGFR- and ALK-dependent NSCLC show blood-brain barrier penetration.
- These therapies have led to significant improvements in central nervous system outcomes.
- Oncogene-driven tumor therapies and immunotherapies demonstrate promise in clinical studies.
Conclusions:
- Emerging targeted therapies and immunotherapies are transforming treatment paradigms for NSCLC brain metastases.
- Combined with advanced radiation techniques, these approaches offer improved prognosis.
- Further research is crucial for optimizing treatment strategies and patient outcomes.
More Related Videos
09:48Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012
Related Concept Videos
Treatment Resistant Cancers
Functional Brain Systems: Limbic System
Functional Brain Systems: Reticular Formation
Within the reticular formation, there are several distinct nuclei that can be classified into three broad categories. The Raphe nuclei are located along the midline of the brainstem. They are primarily known for their role in synthesizing and releasing serotonin, a neurotransmitter involved in regulating mood, appetite, sleep, and circadian rhythms. The...
Lung Capacity
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...